Pharma · Public company · Indianapolis, IN, US

ELI LILLY & Co

Ticker LLY · SEC CIK 0000059478

Track this companyFree. Adds ELI LILLY & Co to your Dealase workspace and tells you when its record changes.

Clinical trials2525 recruiting or active

Pipeline programs55From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline55

BaricitinibPhase 3 · Areata AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
CisplatinPhase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
DulaglutidePhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
LY3537982Phase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
LY3650150Phase 3 · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)ClinicalTrials.gov · fetched Nov 12, 2026
OrforglipronPhase 3 · OverweightClinicalTrials.gov · fetched Nov 12, 2026
OrforglipronPhase 3 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 3 · Carcinoma, Non-Small-Cell LungClinicalTrials.gov · fetched Nov 12, 2026
RetatrutidePhase 3 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
Standard therapy for INCSPhase 3 · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)ClinicalTrials.gov · fetched Nov 12, 2026
BimagrumabPhase 2 · Heart Failure, DiastolicClinicalTrials.gov · fetched Nov 12, 2026
BrenipatidePhase 2 · Pulmonary Disease, Chronic ObstructiveClinicalTrials.gov · fetched Nov 12, 2026
BrenipatidePhase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
BrenipatidePhase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
LY3016859 ISAPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
LY3526318 ISAPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
LY3537031Phase 2 · Irritable Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
LY3556050 ISAPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
LY3857210 ISAPhase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
bevacizumabPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
CaffeinePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
carboplatinPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
CisplatinPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
DigoxinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
DigoxinPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
enfortumab vedotinPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Florbetaben F 18Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Florbetapir F18Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Imlunestrant (Reference)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Imlunestrant (Test)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
ItraconazolePhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
ItraconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
LY3981314Phase 1 · Hepatitis Autoimmune DiseaseClinicalTrials.gov · fetched Nov 12, 2026
LY4050784Phase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
LY4052031Phase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
LY4214835Phase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
LY4336619Phase 1 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
LY4405094Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
LY4515100Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
LY4515100 via MADPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
LY4515100 via SADPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
MidazolamPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
OmeprazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
PaclitaxelPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
pembrolizumabPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
PemetrexedPhase 1 · Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Sofe-MPhase 1 · Ovarian NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Sofetabart Mipitecan (Sofe-M)Phase 1 · Endometrial NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Trastuzumab DeruxtecanPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
VepugratinibPhase 1 · Urinary Bladder NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study of LY3981314 in Participants With Autoimmune HepatitisPHASE1 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07928219 · fetched Nov 12, 2026
A Study of LY4336619 in Adult Participants With Advanced Solid TumorsPHASE1 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07928258 · fetched Nov 12, 2026
A Study of Brenipatide in Participants With Major Depressive DisorderPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07928245 · fetched Nov 12, 2026
A Study of Bimagrumab in Participants With HFpEFPHASE2 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07920887 · fetched Nov 12, 2026
A Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsPHASE1 · NOT_YET_RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT07918859 · fetched Nov 12, 2026
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's DiseasePHASE1 · RECRUITING · started Sep 9, 2026ClinicalTrials.gov NCT07787169 · fetched Nov 12, 2026
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPHASE3 · RECRUITING · started Aug 26, 2026ClinicalTrials.gov NCT07794579 · fetched Nov 12, 2026
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · RECRUITING · started Aug 7, 2026ClinicalTrials.gov NCT07759245 · fetched Nov 12, 2026
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesPHASE3 · RECRUITING · started Jul 8, 2026ClinicalTrials.gov NCT07668336 · fetched Nov 12, 2026
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)PHASE2 · RECRUITING · started Apr 29, 2026ClinicalTrials.gov NCT07545772 · fetched Nov 12, 2026
A Study of LY4515100 in Healthy ParticipantsPHASE1 · RECRUITING · started Jan 15, 2026ClinicalTrials.gov NCT07339722 · fetched Nov 12, 2026
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With CancerPHASE1 · RECRUITING · started Dec 22, 2025ClinicalTrials.gov NCT07258836 · fetched Nov 12, 2026
A Study of Retatrutide (LY3437943) in Participants With Obesity or OverweightPHASE3 · ACTIVE_NOT_RECRUITING · started Nov 17, 2025ClinicalTrials.gov NCT07232719 · fetched Nov 12, 2026
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaPHASE2 · RECRUITING · started Oct 22, 2025ClinicalTrials.gov NCT07219173 · fetched Nov 12, 2026
A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Sep 19, 2024ClinicalTrials.gov NCT06561685 · fetched Nov 12, 2026
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPHASE1 · RECRUITING · started Jul 1, 2024ClinicalTrials.gov NCT06465069 · fetched Nov 12, 2026
A Study of Sofe-M in Participants With Selected Advanced Solid TumorsPHASE1 · RECRUITING · started May 20, 2024ClinicalTrials.gov NCT06400472 · fetched Nov 12, 2026
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)PHASE3 · RECRUITING · started Apr 29, 2024ClinicalTrials.gov NCT06338995 · fetched Nov 12, 2026
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPHASE3 · RECRUITING · started Dec 21, 2023ClinicalTrials.gov NCT06119581 · fetched Nov 12, 2026
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia AreataPHASE3 · RECRUITING · started Feb 27, 2023ClinicalTrials.gov NCT05723198 · fetched Nov 12, 2026
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3PHASE1 · RECRUITING · started Jan 12, 2023ClinicalTrials.gov NCT05614739 · fetched Nov 12, 2026
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 21, 2020ClinicalTrials.gov NCT04607421 · fetched Nov 12, 2026
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's SyndromePHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 25, 2020ClinicalTrials.gov NCT04623541 · fetched Nov 12, 2026
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPHASE2 · RECRUITING · started Jan 30, 2020ClinicalTrials.gov NCT05986292 · fetched Nov 12, 2026
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate CancerPHASE2 · ACTIVE_NOT_RECRUITING · started May 3, 2016ClinicalTrials.gov NCT02452008 · fetched Nov 12, 2026

SEC filings12

10-Q · 10-QSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Oct 29, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
10-K · 10-KSEC EDGAR · filed Feb 12, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 4, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Nov 21, 2025 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Oct 30, 2025 · fetched Nov 12, 2026